July 2020 News

      Like many other laboratories with expertise with antibody production we have focused some urgent attention on the SARS-Cov2 virus and the ACE2 protein which it uses to enter and infect human cells. The region of the virus spike or S-protein and the corresponding virus binding region on the ACE2 protein were recently characterized so we made recombinant forms of both regions in E. coli (Prot-r-SARS-CoV2-bd and Prot-r-ACE2-bd). We now have a panel of excellent mouse monoclonal antibodies to the ACE2 binding site of the SARS-CoV2 S-protein, and are marketing the first two of these, MCA-5G8 and MCA-2G1. We also made an affinity purified rabbit polyclonal antibody raised against the same immunogen, RPCA-SARS-CoV2-bd. These antibodies can be used to identify the SARS-Cov2 virus on western blots and by immunofluorescence and may also block the binding of the virus to ACE2. Of general interest to the world, the SARS-CoV2 S-protein ACE2 binding region turns out to be an excellent immunogen, so that it is likely an ideal target for vaccine development.
      We release new antibodies to β-synuclein, a mouse monoclonal and a rabbit polyclonal, MCA-6A10 and RPCA-SNCB. β-synuclein, like the closely related α-synuclein, is a major brain protein concentrated in synaptic regions. We also release new antibodies to Annexin A5 MCA-6A12 and RPCA-ANXA5. Annexin A5 is a Calcium and membrane associated protein which is upregulated when cells become apoptotic. We also release two new mouse monoclonals directed against PEA-15 MCA-4D2 and MCA-4D117. This protein was discovered as a “phosphoprotein enriched in astrocytes of 15kDa” (PEA-15) and independently as a “protein enriched in diabetes” (PED) and so is sometimes referred to as PED/PEA-15. PEA-15 is one of the large family of proteins containing a death effector domain (DED) and appears to have important functions in the regulation of cell growth, apoptosis and glucose metabolism. Finally we release a goat polyclonal antibody to myelin basic protein, GPCA-MBP, which can be used to identify and study myelin sheathes, oligodendrocytes and certain types of Schwann cell.

May 2020 News

      As every other company we have been affected over the last couple of months by the Covid-19 situation. However we continue to do essential work with reduced hours and remain open for business. We have been shipping to our various OEM partners as before, and, since the receiving departments of many university, company and research institutes are closed down we can and have been shipping to researchers home addresses. We have also initiated some SARS-CoV-2 related research which will result in some new products, including recombinant forms of the cell binding domain of the major coat protein of the SARS-CoV-2 virus PROT-SARS-CoV2-bd and the extracellular domain of the angiotensin converting enzyme 2 (ACE2), now known to be where the SARS-CoV-1 and SARS-CoV-2 viruses bind to the surface of human cells, PROT-ACE2-bd. This binding interaction is essential for virus internalization and infectivity so that antibodies and other reagents that interfere with this specific interface are of great potential clinical interest. We also add more data on the properties and utility of our older products. For example we have epitope mapped our widely used monoclonal antibody to UCHL1 MCA-BH7 and now show that our chicken antibody to tyrosine hydroxylase CPCA-TH can be used to isolate TH positive PBMCs by fluorescent cell sorting. For details of this see Gopinath et al. (2020), another EnCor/academia collaborative study.